India Finds Two More Toxic Syrups Months After Poisoning Deaths

NEW DELHI: India’s drug regulator has found that a cough syrup and an anti-allergy syrup made by Norris Medicines are toxic, according to a government report, months after Indian-made cough syrups were linked to 141 children’s deaths worldwide.

The Central Drugs Standard Control Organisation (CDSCO) has also found three batches of COLD OUT syrup made by Fourrts (India) Laboratories contaminated with the toxins diethylene glycol (DEG) and ethylene glycol (EG), according to its list of “not of standard quality/spurious/adulterated/misbranded” drugs for August uploaded on its website.

Total 11 samples were found contaminated with Ethylene Glycol and samples of Cyproheptadine HCl with Tricholine Citrate Syrup (Sylpro Plus Syrup) Batch No. 33002 and Cold Out Syrup Batch No. SF001A0 1 and SF001A0 2  Manufactured by Norris Medicines Limited, Plot No. 801/P, 901/4-5, G.I.D.C. Estate, Ankleshwar – 393 002 (Gujarat) found to contain Diethylene Glycol. 

The drug regulator for Gujarat state, where Norris is based, told Reuters that its factory had been closed.

Related Posts

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

Can a drug licence be suspended before a hearing? Karnataka HC explains rule

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs